|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PRN | Corporate Officer/Principal | 59 | - |
Dana Lee
PRN | Corporate Officer/Principal | 62 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | +7.56% | +3.61% | +9.84% | 49.92B | ||
| +0.40% | -1.37% | +401.69% | +625.15% | 40.23B | ||
| -0.52% | +6.57% | +25.41% | -5.37% | 34.55B | ||
| +3.97% | +6.71% | +26.06% | +63.36% | 33.09B | ||
| -4.19% | -1.84% | +3.76% | +32.17% | 27.51B | ||
| -2.40% | +1.60% | - | - | 17.05B | ||
| +1.34% | +5.68% | +75.77% | +141.51% | 15.92B | ||
| -0.95% | +0.76% | +12.92% | +21.59% | 13.86B | ||
| +1.69% | +3.09% | +93.44% | +99.19% | 13.52B | ||
| Average | +0.05% | +4.25% | +80.33% | +123.43% | 27.3B | |
| Weighted average by Cap. | +0.24% | +4.49% | +91.13% | +141.43% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















